Genelux Corporation Common Stock (GNLX)
Healthcare
Biotechnology
3.00 $
-3.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Genelux Corporation Common Stock (GNLX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.5% of the shares are freely tradable; institutional investors hold 30.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
30.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
12.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
80.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
45Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | 4.72 | 2,117,183 | +9.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.78 | 1,695,480 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 3.46 | 1,551,449 | +9.3 | 12/31/2025 |
| Bleichroeder LP | 3.08 | 1,380,666 | +93.4 | 03/31/2026 |
| Geode Capital Management, LLC | 1.01 | 453,761 | +19.0 | 03/31/2026 |
| BlackRock Inc | 0.91 | 405,872 | +5.3 | 03/31/2026 |
| Bank of America Corp | 0.72 | 323,865 | -3.6 | 03/31/2026 |
| F.L.Putnam Investment Management | 0.63 | 280,904 | -7.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.66 | 1,191,126 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.05 | 468,996 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.